Hepatitis A vaccination in developing countries: Is Syria next? - Wikidata - awgldk - TriplyDB

Hepatitis A vaccination in developing countries: Is Syria next?

Hepatitis A vaccination in developing countries: Is Syria next?

http://www.wikidata.org/entity/Q36970157

about

Hepatitis A among refugees, asylum seekers and migrants living in hosting facilities, Greece, April to December 2016.Progressive liver failure post acute hepatitis A, over a three-month period, resulting in hepatorenal syndrome and death.

P2860

Q33553107-82B7A568-F628-48B6-A78D-E57EE78FAB02 Q38379988-F79275FA-9492-4C17-BE4A-4241922919BC

P2860

Hepatitis A vaccination in developing countries: Is Syria next?

http://www.wikidata.org/entity/Q36970157

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Hepatitis A vaccination in developing countries: Is Syria next?

@en

type

label

Hepatitis A vaccination in developing countries: Is Syria next?

@en

prefLabel

Hepatitis A vaccination in developing countries: Is Syria next?

@en

P1433

Q36970157-0E8020D4-54E3-47E5-B9C5-6F1E0DE3D3CD

P1476

Q36970157-1693BF0A-482D-4560-8399-358359ADD6D4

P2093

Q36970157-1A57E176-887B-4E1C-95BB-37022C254722

Q36970157-39231A07-81DF-4782-BF3E-D81C582C2111

Q36970157-942E2B3D-EAE9-4929-A7C7-382A0F27CBAD

Q36970157-9A5A0506-6D12-4721-95F1-8A475B408BD2

P2860

Q36970157-07389D67-33E8-4FD0-A245-1D683EB9FDB2

Q36970157-0A63B5DB-A664-4A44-B5DB-6CB650FDD1C7

Q36970157-1F70C872-D5C8-4C8A-8488-F234D0287EA6

Q36970157-4D2BF94B-DBC4-4140-A58A-A2C4CC9FF3F8

Q36970157-638BFA2C-C80F-41B0-9D90-6B8339269955

Q36970157-87D29D3F-F71E-45BC-B0E8-7D5083E8505E

Q36970157-A0EB931F-A592-4B35-AA90-FFD6687F9911

Q36970157-A19E06E6-492C-4DF5-B2FA-1CC0A0F6B0C6

Q36970157-A4FC8E35-C8DB-482E-9D56-D4AABDFA40B9

Q36970157-AF1EABB2-67B8-42F4-A868-3BBEA8736F73

P304

Q36970157-00FDB138-10A1-49C7-9B0D-9610E45306CF

P31

Q36970157-C6F02EF1-EE38-40A8-8197-306B56443106

P356

Q36970157-CAF908FC-50E3-4422-9181-344825887F9E

P433

Q36970157-C8C4DF0F-2C2A-4274-8A24-8AD72A1C3236

P478

Q36970157-F4A03B73-3CA2-4A3C-927B-95CBAA0C02BB

P577

Q36970157-CAA94EBB-0B5D-4C79-8827-A2B691FFA598

P698

Q36970157-C2AB807B-D7E6-452A-8DD6-2F4FAAEA5E43

P921

Q36970157-26CE08AA-0751-4DB0-8B2F-808099739E2F

P932

Q36970157-ABCF65CE-B5B2-4F78-9896-B1EB2DEB2C0E

P356

2231-0770.102284

P1433

Avicenna journal of medicine

P1476

Hepatitis A vaccination in developing countries: Is Syria next?

@en

P2093

Ghaith Habboub

http://www.w3.org/2001/XMLSchema#string

Ghaith Mousabasha

http://www.w3.org/2001/XMLSchema#string

Shadi M Alhalabi

http://www.w3.org/2001/XMLSchema#string

Zaid Al-Faham

http://www.w3.org/2001/XMLSchema#string

P2860

Two-year review of hepatitis A vaccine safety: data from the Vaccine Adverse Event Reporting System (VAERS).

Hepatitis A shifting epidemiology in South-East Asia and China.

Hepatitis A and hepatitis B vaccination of patients with chronic liver disease.

The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns.

Relapsing hepatitis A. Review of 14 cases and literature survey.

Safety and immunogenicity of an inactivated hepatitis A vaccine: effect of dose and vaccination schedule.

Hepatitis A seroprevalence rate in Syria.

The seroepidemiology of Hepatitis A virus in Amman, Jordan.

Frequency of illness associated with epidemic hepatitis A virus infections in adults.

Incidence of hepatitis A in the United States in the era of vaccination.

P304

77-78

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/2231-0770.102284

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23826552

http://www.w3.org/2001/XMLSchema#string

P921

P932

3697427

http://www.w3.org/2001/XMLSchema#string